| abstract |
A method for administering a glucocorticoid receptor antagonist to treat a patient diagnosed with delirium is provided. The present invention relates generally to the field of psychiatry. In particular, the present invention relates to the discovery that agents that inhibit the binding of cortisol to its receptor can be used in methods for treating delirium. Mifepristone, a potent specific glucocorticoid receptor antagonist, can be used in these methods. The present invention also provides a kit for treating delirium in a human. The kit includes instructions that teach glucocorticoid receptor antagonists and their signs, dosages, and dosing schedules. [Selection figure] None |